REFERENCES
1. Mathews TJ, Hamilton BE. Delayed Childbearing: More Women are Having their First Child Later in Life. NCHS data brief, No. 21. Hyattsville, MD: National Center for Health Statistics; 2009.
2. World Health Organization. Family planning/contraception. Fact sheet No. 351. Updated May 2015. Available at: http://www.who. int∕mediacentre∕factsheets∕fs351∕en∕ (accessed 22 March 2016).
3. Royal College of Obstetricians and Gynaecologists (RCOG). Obstetric Impact OfTreatmentfor Cervical Intraepithelial Neoplasia. Scientific Impact Paper No. 21. London: RCOG; 2010.
4. Nauth HF. Gynecologic Cytology. Stuttgart: Thieme; 2007.
5. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
6. National Cancer Institute. Cervical Cancer Screening-Health Professional Version (PDQ"). Available at: http√∕www.cancer. gov∕types∕cervical∕hp∕cervical-screening-pdq⅛link∕-248-toc (accessed 22 March 2016).
7. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-ana- lysis. Obstet Gynecol 1998;92:727-35.
8. McIntyre-Seltman K, Lesnock J. Cervical cancer screening in pregnancy. Obstet Gynecol Clin North Am 2008;35:645-58.
9. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119:1108-24.
10. Royal College of Obstetricians and Gynaecologists (RCOG).
Cervical smears and pregnancy. Available at: https√∕www.rcog. org.uk∕globalassets∕documents∕patients∕patient-information- leaflets∕pregnancy∕cervical-smears-and-pregnancy.pdf (accessed 22 March 2016).11. Saslow D, Castle P, Myers E, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
12. Saslow D, Herschel WL, Waldman J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit TractDis 2012;16:175-204.
13. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997;17:99-107.
14. Arias-Stella J. A topographic study of uterine epithelial atypia associated with chorionic tissue: demonstration of alteration in the endocervix. Cancer 1959;12:782-90.
15. Murad TM, Tehart K, Flint A. Atypical cells in pregnancy and postpartum smears. Acta Cytol 1981;25:623-30.
16. Shrago SS. The Arias-Stella reaction; a case report of a cytologic presentation. Acta Cytol 1977;21:310-13.
17. Sellors JW, Sankaranarayanan R. Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginners’ Manual. Lyon: International Agency for Research on Cancer; 2003.
18. Slama J, Freitag P, Dundr P, et al. Outcomes of pregnant patients with Pap smears classified as atypical glandular cells. Cytopathology 2012;23:383-88.
19. Freeman-Wang T, Walker P. Colposcopy in special circumstances: pregnancy, immunocompromise, including HIV and transplants, adolescence and menopause. Clin Obstet Gynecol 2011;25:653-65.
20. Coppleson M, Pixley E, Reid BL. Colposcopy: A Scientific Approach to the Cervix, Vagina and Vulva in Health and Disease, 3rd edn.
Springfield, IL: 'Thomas; 1986.21. Serati M, Uccella S, Laterza RM. Natural history of cervical intraepithelial neoplasia during pregnancy. Acta Obstet Gynecol Scand 2008;87:1296-300.
22. Tidy J. Colposcopy and Programme Management, 3rd ed. London: Public Health England; 2016.
23. Han SN, Mhallem Gziri M, Van Calsteren K, Amant F. Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies Ther Adv Med Oncol 2013;5:211-19.
24. Ungar L, Smith JR, Palfalvi L, Del Priore G. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet Gynecol 2006;108:811-14.
25. da Fonseca AJ, Dalla-Benetta AC, Ferreira LP, Martins CR, Lins CD. Neoadjuvant chemotherapy followed by radical surgery in pregnant patient with invasive cervical cancer: case report and literature review. RevBras Ginecol Obstet 2011;33:43-48.
26. Siristatidis C, Vitoratos N, Michailidis E, et al. The role of the mode of delivery in the alteration of intrapartum pathological cervical cytologic findings during the postpartum period. Eur J Gynaecol Oncol 2002;23:358-60.
27. Cubo-Abert M, Centeno-Mediavilla C, Franco-Zabala P, et al. Risk factors for progression or persistence of squamous intraepithelial lesions diagnosed during pregnancy. J Low Genit TractDis 2012;16:34-38.
28. Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010;118:450-54.
29. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV Condyloma in pregnancy is strongly predictive ofjuvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003;101:645-52.
30. Paraskevaidis E, Koliopoulos G, Kalantaridou S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol 2002;104:67-69.
31. Jain AG, Higgins RV, Boyle MJ. Management of low-grade squamous intraepithelial lesions during pregnancy.
Am J Obstet Gynecol 1997;177:298-302.32. Palle C, Bangsboll S, Andreasson B. Cervical intraepithelial neoplasia in pregnancy. Acta Obstet Gynecol Scand 2000;79:306-10.
33. Benedet JL, Selke PA, Nickerson KG. Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy. Am J Obstet Gynecol 1987;157:932-37.
34. Kennedy S, Robinson J, Hallam N. LLETZ and infertility. Br J Obstetr Gynaecol 1993;100:965.
35. Luesley DM, McCrum A, Terry PB, et al. Complications of cone biopsy related to the dimensions of the cone and the influence of prior colposcopic assessment. Br J Obstetr Gynaecol 1985;92:158-64.
36. Kalliala I, Anttila A, Dyba T, Hakulinen T, Halttunen M, Nieminen P. Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort study. Br J Obstetr Gynaecol 2012;119:227-35.
37. Spracklen CN, Harland KK, Stegmann BJ, Saftlas AF. Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study. Br J Obstetr Gynaecol 2013;120:960-65.
38. Kyrgiou M, Mitra A, Arbyn M, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis BMJ 2014;349: g6192.
39. Kyrgiou M, Koliopoulos G, Martin- Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis Lancet 2006;367:489-98.
40. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284.
41. Danhof NA, Kamphuis EI, Limpens J, van Lonkhuijzen LR, Pajkrt E, Mol BW. The risk of preterm birth of treated versus untreated cervical intraepithelial neoplasia (CIN): a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2015;188:24-33.
42. Castanon A, Brocklehurst P, Evans H, et al. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-p ro- spective cohort study. BMJ 2012:345:e5174.
43. Founta C, Arbyn M, Valasoulis G, et al. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG 2010;117:1468-74.
44. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000;2:CD001318.
45. Paraskevaidis E, Kyrgiou M, Martin-Hirsch P. Have we dismissed ablative treatment too soon in colposcopy practice? BJOG 2007;114:3-4.
46. Pepas L, Kaushik S, Nordin A, Bryant A, Lawrie TA. Medical interventions for high-grade vulval intraepithelial neoplasia. Cochrane Database Syst Rev 2015;8:CD007924.
47. Joura EA, Losch A, Haider-Angeler MG, et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000;45:613-15.
48. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;107:1018-22.
49. Seters MV. Vulvar Intraepithelial Neoplasia: New Concepts and Strategy. Thesis, Erasmus University, Rotterdam, The Netherlands; 2008.
50. Jones RW, Rowan DR, Stewart AW. Vulvar intraepithelial neoplasia. Aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005;106;1319-26.
51. Food and Drug Administration. Highlights of prescribing information Aldara’ (imiquimod). 2010. Available at: http://www. accessdata.fda.gov/drugsatfda_docs/label/2010/020723s022lbl. pdf (accessed 22 March 2016).
52. Public Health England Knowledge and Intelligence Team for East Midlands. Outline of Uterine Cancer in the United Kingdom: Incidence, Mortality and Survival. Gynaecological Cancer SSCRG.
London: National Cancer Intelligence Network UK; 2013.53. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403-12.
54. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012;27:1327-331.
55. Bobrowska K, Kaminski P, Cyganek A, et al. High rate of endometrial hyperplasia in renal transplanted women. Transplant Proc 2006;38:177-79.
56. Hardiman P, Pillay O, Atiomo W Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810-12.
57. Atiomo W, Khalid S, Parameshweran S, Houda M, Layfield R. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG 2009;116:137-43.
58. Royal College of Obstetricians and Gynaecologists (RCOG). Long- term Consequences of Polycystic Ovary Syndrome. Green-top Guideline No. 33. London: RCOG; 2014.
59. American College of Obstetricians and Gynecologists, Society of Gynecologic Oncology. Practice Bulletin No. 149: Endometrial cancer. Obstet Gynecol 2015;125:1006-26.
60. Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertilitysparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 2012;207:266.e1-12.
61. Royal College of Obstetricians and Gynaecologists (RCOG). Management of Endometrial Hyperplasia. Green-top Guideline No. 67, RCOG/BSGE Joint Guideline. London: RCOG; 2016.